Konica Minolta and Fovia Announce Partnership
Artificial Intelligence Collaboration Showcased at RSNA 2024
Harnessing AWS cloud technology to bring the most advanced diagnostic capabilities to the greatest number of people, the innovative collaboration will provide flexibility for clinicians while offering significant advantages in cost management to healthcare organizations. The additional power and versatility will provide maximum scalability for Exa PACS.
An integration featuring Fovia's artificial intelligence technology, F.A.S.T.® aiCockpit®, within Konica Minolta's Exa PACS can be explored in Konica Minolta's Future's Lab at RSNA, booth #2352 (South Hall). Experience how to efficiently access, interact with and modify AI results from all linked algorithms and workflows in one place.
"Konica Minolta's goal is to provide our customers with the most innovative solutions that enable them to provide the best care possible to their patients," said
"We are excited to partner with Konica Minolta and thrilled with the direction of their best-in-class Exa PACS Server-Side Rendering (SSR) and Diagnostic Zero Footprint (ZFP) technology," stated
Visit Fovia (Booth #4714) and Konica Minolta (Booth #2352) at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America,
About Konica Minolta
Konica Minolta Healthcare is a world-class provider and market leader in medical diagnostic imaging and healthcare information technology. The company's focus is to contribute to life changing advances through the transformation of primary imaging, allowing the invisible to be seen. Primary imaging, the most commonly used medical imaging technologies, include X-ray, ultrasound and imaging management systems. By advancing these readily available technologies, we can bring greater diagnostic capabilities to the greatest number of people.
With 150 years of endless innovation, imaging is in Konica Minolta's DNA. From roots as a camera and film manufacturer, the company has cultivated its own technologies and continues to evolve techniques for visualizing what is not visible. Innovation allows the company to be a strong strategic partner, understanding what value means to customers and how Konica Minolta's innovations can address specific needs and lead to better decisions, sooner.
Konica Minolta Healthcare Americas, Inc., headquartered in
About Fovia
Fovia, Inc. is a world leader in advanced visualization, a preeminent provider of cloud-based, zero-footprint imaging SDKs, and the developer of High Definition Volume Rendering®, XStream® HDVR®, F.A.S.T.® Hybrid Rendering, F.A.S.T.® Interactive Segmentation, RapidPrint® and TruRender®. Fovia's XStream HDVR platform allows its OEM medical partners to incorporate unparalleled advanced visualization into their radiology and artificial intelligence product lines. With Fovia's F.A.S.T.® Cloud SDK, developers can create zero-footprint applications and distribute them across any web-enabled device. Through Fovia's subsidiary, Fovia Ai, Inc., and its flagship products, F.A.S.T.® aiCockpit® and F.A.S.T.® AI SDK, radiologists and clinicians can efficiently access AI results directly within their existing workflows from any PACS, worklist, dictation software or hospital system. Fovia's flexible architecture and 20+ years of radiology integration experience facilitate seamless integrations with a variety of partners, platforms, processors and operating systems.
For additional information and to learn more about commercial, academic or research licensing, visit fovia.ai or fovia.com.
IMPORTANT REGULATORY NOTICE: Some of the applications mentioned herein are for investigational use only at this time.
View original content to download multimedia:https://www.prnewswire.com/news-releases/konica-minolta-and-fovia-announce-partnership-302317840.html
SOURCE Fovia Ai
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TAPP Engine to Enhance Digital Wealth Experiences for Credit Unions and Community Banks with Envestnet's ActivePassive ETF Model Portfolios
- One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns
- AM Best Affirms Credit Ratings of Société Tunisienne de Réassurance
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share